Categories: News

Onset Announces NEW Ultra-Low Temperature Data Logger for the Storage and Transportation of Vaccines and Pharmaceuticals

BOURNE, Mass., Jan. 11, 2021 /PRNewswire/ — Onset, a trusted manufacturer of field-proven data loggers for 40 years, today released a new ultra-low temperature data logger specifically designed for vaccine and pharmaceutical monitoring in storage and transportation environments – the new InTemp CX405-RTD Dry Ice Data Logger with visual display.  

The CX405 leverages Bluetooth Low Energy (BLE) technology for convenient wireless communication with Onset’s InTemp mobile application and/or InTemp CX5000 Gateway. Users can easily configure loggers, read out data, and automatically upload reports to InTempConnect, Onset’s cloud platform for command-center control over all logger deployments throughout a user’s global supply chain. 

With a built-in 1.5 m external probe that measures temperatures as low as -95°C (-139°F) and up to 50°C (122°F) with a high degree of accuracy, the CX405 provides reliable monitoring throughout the cold chain, from dry ice to freezer/refrigerator conditions. Equipped with an anti-cut sheath to prevent damage to the probe cable, the data logger also features a built-in LCD screen that displays current temperature, visual alarms, battery level, and minimum and maximum readings. The CX405 is built to FDA, USP, EU, and WHO standards, and is NIST-calibrated with a 2-year NIST calibration certificate (probe only).

“The InTemp CX405 combines highly accurate measurements at ultra-low temperatures with an LCD screen that displays temperature data to ensure vaccine and pharmaceutical efficacy throughout the storage and transportation process,” said Jamie Pearce, Onset InTemp Vice President and General Manager. “And when the logger is coupled with the CX5000 Gateway, users can receive real-time email and/or text notifications of temperature excursions, so they can act quickly to ensure the integrity of products passing through a stopover location or stored at their facility.”

For more information about the InTemp CX405-RTD data logger, or to place an order, customers can contact Onset at https://www.onsetcomp.com/intemp/contact/sales.

About InTemp

InTemp, a division of Onset, provides Cold Chain monitoring and software solutions for the storage and transportation of environmentally-sensitive life science and health care products, empowering users with greater control and visibility of secure, actionable, and accurate monitoring data. To learn more visit https://www.onsetcomp.com/intemp.

About Onset

Onset is a leading supplier of data loggers and monitoring solutions used to measure, record, and manage data for improving the environment and preserving the quality of temperature-sensitive products. Based on Cape Cod, Massachusetts, Onset has been designing and manufacturing its products on site since the company’s founding in 1981. Visit Onset on the web at https://www.onsetcomp.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/onset-announces-new-ultra-low-temperature-data-logger-for-the-storage-and-transportation-of-vaccines-and-pharmaceuticals-301204790.html

SOURCE Onset

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

7 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

10 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

10 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

10 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

10 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

10 hours ago